Tech Company Financing Transactions
Omniome Funding Round
Omniome, operating out of San Diego, secured $60 million from Decheng Capital, Hillhouse Capital Group and Altitude Life Science Ventures.
Transaction Overview
Company Name
Announced On
7/31/2018
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series B
Investors
Proceeds Purpose
A portion of the proceeds from the financing will be used to expand the company's capabilities by hiring new team members across multiple disciplines, particularly in engineering, and building out additional research and production capacity.
Company Information
Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
6965 Lusk Blvd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
At Omniome, we are developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy. The accuracy of our novel sequencing approach has the potential to advance cancer diagnostics, drive higher fidelity for single-cell applications, and broadly enable clinical sequencing--even in regions of the genome prone to sequencing errors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ken Song
Chief Executive Officer
David Mullarkey
Chief Technical Officer
Arnold Oliphant
VP - Bus. Development
Marc Montserrat
VP - Finance
Kelly Perez
Browse more venture capital transactions:
Prev: 7/31/2018: Alignable venture capital transaction
Next: 7/31/2018: VUV Analytics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs